MedPage Today on MSN2d
Evolut Low Risk TAVR Still Chugging Along, Now Halfway to Trial's Finish Line
CHICAGO -- Transcatheter aortic valve replacement (TAVR) continued to hold its own against surgery for younger patients at ...
TCTMD2d
Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years
The follow-up brought little surprise, with investigators pleased the risk of death/disabling stroke remained on par with ...
Five-year outcomes similar for low-risk patients receiving transcatheter, surgical aortic valve replacement
Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter ...
Healio2d
TAVR remains noninferior to surgery for low-risk patients at 5 years
Among patients with severe aortic stenosis at low surgical risk, transcatheter aortic valve replacement and surgery conferred ...
Medical News Today13d
Dr. Michael Reardon, MD
Dr. Michael Reardon, MD works in Winston Salem, NC as a Diagnostic Radiologist. Dr. Reardon is board certified in Diagnostic Radiology. Dr. Reardon is affiliated with Novant Health Thomasville ...